Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 23, 2014
Pharmacy Choice - News - Front Page Healthcare News - July 23, 2014

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/23/14 - A collection of approx..1100 FDA approved drugs in pre-dissolved 100ul of DMSO solution for high throughput screening (HTS) and high content... [TendersInfo (India)]
A collection of approx.. 1100 FDA approved drugs in pre-dissolved 100 ul of DMSO solution for high throughput screening and high content screening. Contract awarded for A collection of approx.. 1100 FDA approved drugs in pre-dissolved 100 ul of DMSO solution for high throughput screening and high content screening. Contractor address: 211 Henderson
7/23/14 - Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Generic Food and Drug Administration Rapid...
Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Generic Food and Drug Administration Rapid Response Surveys. SUMMARY: The Food and Drug Administration is announcing that a collection of information entitled "Generic FDA Rapid Response Surveys" has been approved by the Office of Management and Budg
7/23/14 - Astellas Submits U.S. New Drug Application for Isavuconazole for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis
By a News Reporter-Staff News Editor at Biotech Week Astellas announced it has submitted a New Drug Application to the U.S. Food and Drug Administration seeking approval for isavuconazole for the treatment of invasive aspergillosis and invasive mucormycosis, life-threatening fungal infections predominantly occurring in immunocompromised patients.
7/23/14 - ATA Seeks Speakers to Present at the World's Largest Telemedicine, mHealth and Telehealth Conference
The American Telemedicine Association is seeking presenters for ATA 2015, ATA's twentieth annual meeting and tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract over 5,000 attendees and more than 250 cutting-edge healthcare technology vendors, will take place May 3-5, 2015, in Los Angeles.
7/23/14 - Batu Biologics Reaches 50% of Crowdfunding Goal
By a News Reporter-Staff News Editor at Biotech Week Batu Biologics announced that the company successfully rose over 50% of its crowdfunding target to assist in completion of preclinical studies to support the FDA submission of its novel cancer vaccine, ValloVax?. Alan Lewis to our scientific advisory board, "said Samuel Wagner, President and
7/23/14 - Bristol-Myers Squibb Updates on Plans for Third Quarter Submission of a Biologics License Application [Professional Services Close - Up]
Bristol-Myers Squibb Company reported that, following discussions with the U.S. Food and Drug Administration, the company is planning a third quarter submission of a Biologics Licensing Application for Opdivo for previously treated advanced melanoma. According to a release from the company, this will mark the second tumor type for which Bristol-Mye
7/23/14 - CVS Caremark and IBM Announce the "Technology Solutions for Smarter Health" Program in Partnership with the National Association of Community Health Centers
WOONSOCKET, R.I., July 23, 2014/ 3 BL Media/- CVS Caremark, in partnership with IBM, announced a $1.5 million commitment to the " Technology Solutions for Smarter Health" grant program in partnership with the National Association of Community Health Centers. The " Technology Solutions for Smarter Health" grants will be awarded to community health c
7/23/14 - Data on Drug Delivery Systems Detailed by Researchers at Food and Drug Administration (Stereomicroscopic Imaging Technique for the Quantification of...
Data on Drug Delivery Systems Detailed by Researchers at Food and Drug Administration. By a News Reporter-Staff News Editor at Biotech Week Investigators publish new report on Drugs and Therapies. The news correspondents obtained a quote from the research from Food and Drug Administration, "There are no compendial or noncompendial methods availab
7/23/14 - Dompe announces the Food and Drug Administration (FDA) has granted orphan drug designation to its rhNGF-based treatment for neurotrophic keratitis
Dompe, a leader in R&D for new therapeutic solutions for the treatment of rare diseases, announces that rhNGF has been designated as an orphan drug by the American Food and Drug Administration. This is the second orphan drug designation by the FDA for rhNGF, after the recent designation for the treatment of retinitis pigmentosa, a rare genetic di
7/23/14 - eQHealth Solutions Achieves Full URAC Disease Management Accreditation
eQHealth Solutions, a non-profit health management company dedicated to collaborative relationships that enable change in healthcare, has received full Disease Management Accreditation from URAC, a Washington, DC- based accrediting organization that works to establish quality standards for the healthcare industry. URAC granted full accreditations..
7/23/14 - FDA Approves Eagle Pharmaceuticals' Ryanodex For The Treatment Of Malignant Hyperthermia
Eagle Pharmaceuticals, Inc. today announced that the U. S. Food and Drug Administration has approved Ryanodex for injectable suspension indicated for the treatment of malignant hyperthermia, along with the appropriate supportive measures. FDA had designated Ryanodex as an Orphan Drug in August 2013. Eagle has been informed by the FDA that it wil
7/23/14 - FDA Approves Eagle Pharmaceuticals Ryanodex for the Treatment of Malignant Hyperthermia
Eagle Pharmaceuticals, Inc. today announced that the U. S. Food and Drug Administration has approved Ryanodex for injectable suspension indicated for the treatment of malignant hyperthermia, along with the appropriate supportive measures. FDA had designated Ryanodex as an Orphan Drug in August 2013. We are very pleased with today s approva
7/23/14 - IMRIS receives CE mark for integrating latest generation MR scanners within VISIUS Surgical Theatre in European market
-IMRIS Inc. today announced that the Company has obtained regulatory CE mark for integrating the next generation MRI core technology into the VISIUS Surgical Theatre allowing for sales and marketing in the European Union. This newest imaging technology, based on the Siemens Aera 1.5 T and Skyra 3.0 T MRI scanners, helps IMRIS deliver even better
7/23/14 - Lightlake Therapeutics Inc. Signs Agreement With Commercial Contract Manufacturer For Its Opioid Overdose Reversal Treatment
By a News Reporter-Staff News Editor at Biotech Week Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced that it has signed an agreement with a commercial contract manufacturer to commence production of its naloxone-based opioid overdose reversal...
7/23/14 - Louisiana Pain Specialists Becomes First in Southeast Louisiana to Implant Patient Suffering from Chronic Pain with New Spinal Cord Stimulation Device
New Orleans, Louisian July 23, 2014. Nomen Azeem with Louisiana Pain Specialists is the first in Southeast Louisiana to implant the Protg? IPG, the world's first and only neurostimulation system that allows technology upgrades as they are approved to be made via software updates. With this device, Louisiana Pain Specialists is now able to off
7/23/14 - Medical Device Software Seminar: FDA Guidance & Risk Management - 15th October 2014, London, UK
By a News Reporter-Staff News Editor at Journal of Engineering Research and Markets has announced the addition of the " Medical Device Software: FDA Guidance& Risk Management" conference to their offering. This course is aimed towards delegates who have experience with Medical Device Software and wish to gain a better understanding of the complex
7/23/14 - MiMedx Files Its Initial Investigational New Drug Application
MiMedx Group, Inc., an integrated developer, processor and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today it has filed its initial Investigational New Drug application with the Food and Drug Administration. "Pete" Petit, Chairman and CEO, stated, "I am very pleased t
7/23/14 - New Atrial Fibrillation Data Have Been Reported by Investigators at Tampere University Hospital (One-Year Outcome of Patients With Atrial...
New Atrial Fibrillation Data Have Been Reported by Investigators at Tampere University Hospital. According to news reporting from Tampere, Finland, by NewsRx journalists, research stated, "Most evidence regarding the efficacy and safety of the antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary...
7/23/14 - Patent Application Titled "Method of Treatment of Aggression" Published Online
By a News Reporter-Staff News Editor at Biotech Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventor Breder, Christopher D., filed on July 26, 2013, was made available online on July 10, 2014. The assignee for this patent application is Supernus Pharmaceuticals, Inc..
7/23/14 - Protein Sciences Receives Approval from FDA for 2014/15 Formulation of Flublok Influenza Vaccine
By a News Reporter-Staff News Editor at Vaccine Weekly Protein Sciences Corporation announced that the FDA has approved the Company's strain change amendment for its seasonal influenza vaccine, Flublok. She added, "We are still accepting orders for the fall and providers are encouraged to order through our distributors FFF Enterprises and ASD Hea
7/23/14 - Puma Bio More Than $100 After-Hours On Trial PB272; CEL-SCI Receives Regulatory Clearance To Expand Phase III Head And Neck Cancer Trial
A list of the 32 studies found for Puma Biotechnology at ClinicalTrials.gov================================= CEL-SCI Corporation announced Turkey s Ministry of Health has cleared the company to begin patient enrollment in CEL-SCI s global pivotal Phase III Head and Neck Cancer clinical trial of its investigational cancer immunotherapy treatme
7/23/14 - Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Shire plc, the global specialty biopharmaceutical company, and ArmaGen, a US privately held biotechnology company, today announced a worldwide licensing and collaboration agreement for AGT-182, an investigational enzyme replacement therapy for the potential treatment of both the central nervous system and somatic manifestations in patients with...
7/23/14 - Singulex Highlights Development Progress with Ultrasensitive Sgx Clarity? System at AACC 2014
Singulex, Inc., the developer and leading provider of Single Molecule Counting technology for clinical diagnostics and scientific discovery, today outlined development progress toward commercializing, as early as 2016, an ultrasensitive immunoassay system for the in vitro diagnostics market. In a world where protein assay innovation has not adva
7/23/14 - Summit Medical Secures FDA Clearance for Sterilization Methods [Health & Beauty Close - Up]
Summit Medical gain FDA clearance for sterilization methods on their instrument protection trays. According to a release from the company, these validations serve as a safeguard, to ensure the product will not inhibit sterility of valuable surgical instrumentation. Kevin McIntosh- Executive VP and COO of Summit Medical.
7/23/14 - Teleflex Signs New Agreement with Amerinet for Surgical Instruments
Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced a new agreement with Amerinet, a national healthcare solutions organization, for a comprehensive range of surgical instruments. Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Lupus: What You Need to Know
This lesson is supported by:
RxSchool
West Virginia Best Practice Prescribing & Drug Diversion Training
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comPharmacyPages.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415